Hypothesis: Are neoplastic macrophages/ microglia present in glioblastoma multiforme?

ASN Neuro

Volumn 3, Issue 4, 2011, Pages 183-193

  Huysentruyt, Leanne C ^a   Akgoc, Zeynep ^b   Seyfried, Thomas N ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b BOSTON COLLEGE   (United States)

Author keywords

Fusion; Glioblastoma multiforme; Glioma; Macrophage; Microglia; Phagocytosis

Indexed keywords

CELL ANTIGEN;

ANTIGEN EXPRESSION; BIOENERGY; BONE MARROW CELL; CANCER CELL; CANCER GROWTH; CANCER INVASION; CANCER STEM CELL; CELL DIFFERENTIATION; CELL FUNCTION; CELL FUSION; CELL INTERACTION; CELL MIGRATION; CELL POPULATION; CELL PROLIFERATION; CELL STRUCTURE; CELL TYPE; CELL VIABILITY; CENTRAL NERVOUS SYSTEM TUMOR; DISEASE ACTIVITY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; EPITHELIUM CELL; GLIOBLASTOMA; GLIOMA CELL; HUMAN; MACROPHAGE; MALIGNANT TRANSFORMATION; METASTASIS POTENTIAL; MICROGLIA; NONHUMAN; PATHOPHYSIOLOGY; PHAGOCYTE; PHAGOCYTOSIS; REVIEW; TUMOR ASSOCIATED LEUKOCYTE; TUMOR IMMUNITY; TUMOR MICROENVIRONMENT; TUMOR VASCULARIZATION; BRAIN TUMOR; PATHOLOGY;

BRAIN NEOPLASMS; GLIOBLASTOMA; HUMANS; MACROPHAGES; MICROGLIA;

EID: 80054888292     PISSN: None     EISSN: 17590914     Source Type: Journal    
DOI: 10.1042/AN20110011     Document Type: Review

References (138)

1. Ackman JB, Siddiqi F, Walikonis RS, LoTurco JJ (2006) Fusion of microglia with pyramidal neurons after retroviral infection. J Neurosci 26:11413-11422.
2. Alvarez-Dolado M, Pardal R, Garcia-Verdugo JM, Fike JR, Lee HO, Pfeffer K, Lois C, Morrison SJ, Alvarez-Buylla A (2003) Fusion of bone-marrowderived cells with Purkinje neurons, cardiomyocytes and hepatocytes. Nature 425:968-973.
3. Amat JA, Ishiguro H, Nakamura K, Norton WT (1996) Phenotypic diversity and kinetics of proliferating microglia and astrocytes following cortical stab wounds. Glia 16:368-382.
4. Badie B, Schartner JM (2000). Flow cytometric characterization of tumorassociated macrophages in experimental gliomas. Neurosurgery 46: 957-961.
5. Banaei-Bouchareb L, Peuchmaur M, Czernichow P, Polak M (2006) A transient microenvironment loaded mainly with macrophages in the early developing human pancreas. J Endocrinol 188:467-480.
6. Bingle L, Brown NJ, Lewis CE (2002) The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies. J Pathol 196:254-265.
7. Bissell MJ, Hines WC (2011) Why don't we get more cancer? A proposed role of the microenvironment in restraining cancer progression. Nat Med 17:320-329.
8. Biswas SK, Sica A, Lewis CE (2008) Plasticity of macrophage function during tumor progression: regulation by distinct molecular mechanisms. J Immunol 180:2011-2017.
9. Bjerknes R, Bjerkvig R, Laerum OD (1987) Phagocytic capacity of normal and malignant rat glial cells in culture. J Natl Cancer Inst 78:279-288.
10. Bottazzi B, Polentarutti N, Acero R, Balsari A, Boraschi D, Ghezzi P, Salmona M, Mantovani A (1983) Regulation of the macrophage content of neoplasms by chemoattractants. Science 220:210-212.
11. Burke B, Lewis CE (2002) The Macrophage. Oxford University Press, New York.
12. Butow RA, Avadhani NG (2004) Mitochondrial signaling: the retrograde response. Mol Cell 14:1-15.
13. Camargo FD, Chambers SM, Goodell MA (2004a) Stem cell plasticity: from transdifferentiation to macrophage fusion. Cell Prolif 37:55-65.
14. Camargo FD, Finegold M, Goodell MA (2004b) Hematopoietic myelomonocytic cells are the major source of hepatocyte fusion partners. J Clin Invest 113:1266-1270.
15. Chakraborty A, Lazova R, Davies S, Backvall H, Ponten F, Brash D, Pawelek J (2004) Donor DNA in a renal cell carcinoma metastasis from a bone marrow transplant recipient. Bone Marrow Transplant 34:183-186.
16. Chakraborty AK, de Freitas Sousa J, Espreafico EM, Pawelek JM (2001) Human monocyte x mouse melanoma fusion hybrids express human gene. Gene 275:103-106.
17. Chakraborty AK, Sodi S, Rachkovsky M, Kolesnikova N, Platt JT, Bolognia JL, Pawelek JM (2000) A spontaneous murine melanoma lung metastasis comprised of host6tumor hybrids. Cancer Res 60:2512-2519.
18. Chang GH, Barbaro NM, Pieper RO (2000) Phosphatidylserine-dependent phagocytosis of apoptotic glioma cells by normal human microglia, astrocytes, glioma cells. Neuro Oncol 2:174-183.
19. Chettibi S, Ferguson MWJ (1999) Wound repair: an overview. In Inflammation: Basic Principals and Clinical Correlates (Snyderman J, ed.), pp. 865-881. Lippincott Williams and Wilkins, New York.
20. Colman H, Zhang L, Sulman EP, McDonald JM, Shooshtari NL, Rivera A, Popoff S, Nutt CL, Louis DN, Cairncross JG, Gilbert MR, Phillips HS, Mehta MP, Chakravarti A, Pelloski CE, Bhat K, Feuerstein BG, Jenkins RB, Aldape K. (2010) A multigene predictor of outcome in glioblastoma. Neuro Oncol 12:49-57.
21. Coopman PJ, Do MT, Thompson EW, Mueller SC (1998) Phagocytosis of crosslinked gelatin matrix by human breast carcinoma cells correlates with their invasive capacity. Clin Cancer Res 4:507-515.
22. Deininger MH, Meyermann R, Schluesener HJ (2003) Expression and release of CD14 in astrocytic brain tumors. Acta Neuropathol (Berl) 106:271-277.
23. Deininger MH, Seid K, Engel S, Meyermann R, Schluesener HJ (2000) Allograft inflammatory factor-1 defines a distinct subset of infiltrating macrophages/ microglial cells in rat and human gliomas. Acta Neuropathol (Berl) 100:673-680.
24. Duelli D, Lazebnik Y (2003) Cell fusion: a hidden enemy? Cancer Cell 3:445-448.
25. Duffy PE (1983) Astrocytes: Normal, Reactive, and Neoplastic. 224 pp, Raven Press, New York.
26. Dvorak HF (1986). Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med 315:1650-1659.
27. Ecsedy JA, Yohe HC, Bergeron AJ, Seyfried TN (1998) Tumor-infiltrating macrophages contribute to the glycosphinglipid composition of brain tumors. J Lipid Res 39:2218-2227.
28. Fais S (2007) Cannibalism: a way to feed on metastatic tumors. Cancer Lett 258:155-164.
29. Fan X, Salford LG, Widegren B (2007) Glioma stem cells: evidence and limitation. Semin Cancer Biol 17:214-218.
30. Frank S, Kuhn SA, Brodhun M, Mueller U, Romeike B, Kosmehl H, Regenbrecht CR, Ewald C, Reichart R, Kalff R (2009) Metastatic glioblastoma cells use common pathways via blood and lymphatic vessels. Neurol Neurochir Pol 43:183-190.
31. Fraser H (1971) Astrocytomas in an inbred mouse strain. J Pathol 103:266-270.
32. Fraser H (1986) Brain tumours in mice, with particular reference to astrocytoma. Food Chem Toxicol 24:105-111.
33. Frost MT, Wang Q, Moncada S, Singer M (2005) Hypoxia accelerates nitric oxide-dependent inhibition of mitochondrial complex I in activated macrophages. Am J Physiol Regul Integr Comp Physiol 288:R394-R400.
34. Gabrilovich DI, Nagaraj S (2009) Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol 9:162-174.
35. Ghoneum M, Gollapudi S (2004) Phagocytosis of Candida albicans by metastatic and non metastatic human breast cancer cell lines in vitro. Cancer Detect Prev 28:17-26.
36. Ghoneum M, Hamilton J, Brown J, Gollapudi S (2005) Human squamous cell carcinoma of the tongue and colon undergoes apoptosis upon phagocytosis of Saccharomyces cerevisiae, the baker's yeast, in vitro. Anticancer Res 25:981-989.
37. Ghoneum M, Matsuura M, Braga M, Gollapudi S (2008) S. cerevisiae induces apoptosis in human metastatic breast cancer cells by altering intracellular Ca2+ and the ratio of Bax and Bcl-2. Int J Oncol 33:533-539.
38. Ghoneum M, Wang L, Agrawal S, Gollapudi S (2007) Yeast therapy for the treatment of breast cancer: a nude mice model study. In Vivo 21:251-258.
39. Giulian D, Chen J, Ingeman JE, George JK, Noponen M (1989) The role of mononuclear phagocytes in wound healing after traumatic injury to adult mammalian brain. J Neurosci 9:4416-4429.
40. Gordon S (1999) Development and distribution of mononuclear phagocytes: revelance to inflammation. In Inflammation: Basic Principles and Clinical Correlates (Gallin J and Snyderman R, eds), pp. 35-48. Lippincott Williams and Wilkins, New York.
41. Gordon S (2003) Alternative activation of macrophages. Nat Rev Immunol 3:23-35.
42. Gotway MB, Conomos PJ, Bremner RM (2011) Pleural metastatic disease from glioblastoma multiforme. J Thorac Imaging 26:W54-W58.
43. Graeber MB, Scheithauer BW, Kreutzberg GW (2002) Microglia in brain tumors. Glia 40:252-259.
44. Graeber MB, Streit WJ (1990) Microglia: immune network in the CNS. Brain Pathol 1:2-5.
45. Gruss P, Spohr A, Leiber A, Tasler J, Menzl H, Hofstadter F (1993) The traumatic origin of a glioblastoma. Zentralbl Neurochir 54:186-189.
46. Guillemin GJ, Brew BJ (2004) Microglia, macrophages, perivascular macrophages, and pericytes: a review of function and identification. J Leukoc Biol 75:388-397.
47. Han SJ, Yang I, Otero JJ, Ahn BJ, Tihan BJ, McDermott MW, Berger MS, Chang SM, Parsa AT (2010) Secondary gliosarcoma after diagnosis of glioblastoma: clinical experience with 30 consecutive patients. J Neurosurg 112:990-996.
48. Handerson T, Camp R, Harigopal M, Rimm D, Pawelek J (2005) Beta1,6- branched oligosaccharides are increased in lymph node metastases and predict poor outcome in breast carcinoma. Clin Cancer Res 11:2969-2973.
49. Hoffman HJ, Duffner PK (1985) Extraneural metastases of central nervous system tumors. Cancer 56:1778-1782.
50. Homma T, Fukushima T, Vaccarella S, Yonekawa Y, Di Patre PL, Franceschi S, Ohgaki H (2006) Correlation among pathology, genotype, and patient outcomes in glioblastoma. J Neuropathol Exp Neurol 65:846-854.
51. Huysentruyt LC, Mukherjee P, Banerjee D, Shelton LM, Seyfried TN (2008) Metastatic cancer cells with macrophage properties: evidence from a new murine tumor model. Int J Cancer 123:73-84.
52. Huysentruyt LC, Seyfried TN (2010) Perspectives on the mesenchymal origin of metastatic cancer. Cancer Metastasis Rev 29:695-707.
53. Huysentruyt LC, Shelton LM, Seyfried TN (2010) Influence of methotrexate and cisplatin on tumor progression and survival in the VM mouse model of systemic metastatic cancer. Int J Cancer 126:65-72.
54. Kargiotis O, Geka A, Rao JS, Kyritsis AP (2010) Effects of irradiation on tumor cell survival, invasion and angiogenesis. J Neurooncol 100:323-338.
55. Kiebish MA, Han X, Cheng H, Chuang JH, Seyfried TN (2008) Cardiolipin and electron transport chain abnormalities in mouse brain tumor mitochondria: lipidomic evidence supporting the Warburg theory of cancer. J Lipid Res 49:2545-2556.
56. Kiebish MA, Han X, Cheng H, Seyfried TN (2009) In vitro growth environment produces lipidomic and electron transport chain abnormalities in mitochondria from non-tumorigenic astrocytes and brain tumours. ASN NEURO 1:e00011.
57. Krex D, Klink B, Hartmann C, von Deimling A, Pietsch T, Simon M, Sabel M, Steinbach JP, Heese O, Reifenberger G, Weller M, and Schackert G (2007) Long-term survival with glioblastoma multiforme. Brain 130:2596-2606.
58. Lakka SS, Rao JS (2008) Antiangiogenic therapy in brain tumors. Expert Rev Neurother 8:1457-1473.
59. Laws Jr ER, Goldberg WJ, Bernstein JJ (1993) Migration of human malignant astrocytoma cells in the mammalian brain: Scherer revisited. Int J Dev Neurosci 11:691-697.
60. Leek RD, Lewis CE, Whitehouse R, Greenall M, Clarke J, Harris AL (1996) Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. Cancer Res 56:4625-4629.
61. Leenstra S, Das PK, Troost D, de Boer OJ, Bosch DA (1995) Human malignant astrocytes express macrophage phenotype. J. Neuroimmunol 56:17-25.
62. Leung SY, Wong MP, Chung LP, Chan AS, Yuen ST (1997) Monocyte chemoattractant protein-1 expression and macrophage infiltration in gliomas. Acta Neuropathol (Berl) 93:518-527.
63. Lewis C, Murdoch C (2005) Macrophage responses to hypoxia: implications for tumor progression and anti-cancer therapies. Am J Pathol 167:627-635.
64. Lewis CE, Pollard JW (2006) Distinct role of macrophages in different tumor microenvironments. Cancer Res 66:605-612.
65. Mallat M, Marin-Teva JL, Cheret C (2005) Phagocytosis in the developing CNS: more than clearing the corpses. Curr Opin Neurobiol 15:101-107.
66. Mantovani A, Sica A (2010) Macrophages, innate immunity and cancer: balance, tolerance, and diversity. Curr Opin Immunol 22:231-237.
67. Mantovani A, Sozzani S, Locati M, Allavena P, Sica A (2002) Macrophag epolarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol 23:549-555.
68. Martin P, Leibovich SJ (2005) Inflammatory cells during wound repair: the good, the bad and the ugly. Trends Cell Biol 15:599-607.
69. Matyja E, Kroh H, Taraszewska A, Naganska E, Zabek M, Marchel A (2003) Expression of macrophage/histiocytic antigens in pleomorphic xanthoastrocytomas. Folia Neuropathol 41:89-95.
70. Morantz RA, Wood GW, Foster M, Clark M, Gollahon K (1979) Macrop hages inexperimental and human brain tumors. Part 2: studies of the macrophage content of human brain tumors. J Neurosurg 50:305-311.
71. Morimura T, Neuchrist C, Kitz K, Budka H, Scheiner O, Kraft D, Lassmann H (1990) Monocyte subpopulations in human gliomas: expression of Fc and complement receptors and correlation with tumor proliferation. Acta Neuropathol (Berl) 80:287-294.
72. Munzarova M, Kovarik J (1987) Is cancer a macrophage-mediated autoaggressive disease? Lancet 1:952-954.
73. Murdoch C, Giannoudis A, Lewis CE (2004) Mechanisms regulating the recruitment of macrophages into hypoxic areas of tumors and other ischemic tissues. Blood 104:2224-2234.
74. Navarro A, Boveris A (2005) Hypoxia exacerbates macrophage mitochondrial damage in endotoxic shock. Am J Physiol Regul Integr Comp Physiol 288:R354-R355.
75. Ng WH, Yeo TT, Kaye AH (2005) Spinal and extracranial metastatic dissemination of malignant glioma. J Clin Neurosci 12:379-382.
76. Nitta T, Okumura K, Sato K (1992) Lysosomal enzymic activity of astroglial cells. Pathobiology 60:42-44.
77. Ohgaki H, Kleihues P (2005) Epidemiology and etiology of gliomas. Acta Neuropathol (Berl) 109:93-108.
78. Ohgaki H, Kleihues P (2009) Genetic alterations and signaling pathways in the evolution of gliomas. Cancer Sci 100:2235-2241.
79. Ojalvo LS, King W, Cox D, Pollard JW (2009) High-density gene expression analysis of tumor-associated macrophages from mouse mammary tumors. Am J Pathol 174:1048-1064.
80. Ojalvo LS, Whittaker CA, Condeelis JS, Pollard JW (2010) Gene expression analysis of macrophages that facilitate tumor invasion supports a role for Wnt-signaling in mediating their activity in primary mammary tumors. J Immunol 184:702-712.
81. Ordys BB, Launay S, Deighton RF, McCulloch J, Whittle IR (2010) The role of mitochondria in glioma pathophysiology. Mol Neurobiol 42:64-75.
82. Ostrand-Rosenberg S (2010) Myeloid-derived suppressor cells: more mechanisms for inhibiting antitumor immunity. Cancer Immunol Immunother 59:1593-1600.
83. Paulus W, Roggendorf W, Kirchner T (1992) Ki-M1P as a marker for microglia and brain macrophages in routinely processed human tissues. Acta Neuropathol (Berl) 84:538-544.
84. Pawelek JM (2000) Tumour cell hybridization and metastasis revisited. Melanoma Res 10:507-514.
85. Pawelek JM (2005) Tumour-cell fusion as a source of myeloid traits in cancer. Lancet Oncol 6:988-993.
86. Pawelek JM, Chakraborty AK (2008) Fusion of tumour cells with bone marrow-derived cells: a unifying explanation for metastasis. Nat Rev Cancer 8:377-386.
87. Persson A, Englund E (2009) The glioma cell edge-winning by engulfing the enemy? Med Hypotheses 73:336-337.
88. th European Congress of Neuropathology Clinical Neuropathology, Athens, Greece, p. 194.
89. Pollard JW (2008) Macrophages define the invasive microenvironment in breast cancer. J Leukoc Biol 84:623-630.
90. Powell AE, Anderson EC, Davies PS, Silk AD, Pelz C, Impey S, Wong MH (2011) Fusion between intestinal epithelial cells and macrophages in a cancer context results in nuclear reprogramming. Cancer Res 71:1497-1505.
91. Preusser M, de Ribaupierre S, Wohrer A, Erridge SC, Hegi M, Weller M, Stupp R (2011) Current concepts and management of glioblastoma. Ann Neurol 70:9-21.
92. Qian BZ, Pollard JW (2010) Macrophage diversity enhances tumor progression and metastasis. Cell 141:39-51.
93. Rachkovsky M, Pawelek J (1999) Acquired melanocyte stimulating hormoneinducible chemotaxis following macrophage fusion with Cloudman S91 melanoma cells. Cell Growth Differ 10:517-524.
94. Rachkovsky M, Sodi S, Chakraborty A, Avissar Y, Bolognia J, McNiff JM, Platt J, Bermudes D, Pawelek J (1998) Melanoma6macrophage hybrids with enhanced metastatic potential. Clin Exp Metastasis 16:299-312.
95. Raychaudhuri B, Rayman P, Ireland J, Ko J, Rini B, Borden EC, Garcia J, Vogelbaum MA, Finke J (2011) Myeloid-derived suppressor cell accumulation and function in patients with newly diagnosed glioblastoma. Neuro Oncol 13:591-599.
96. Ricci-Vitiani L, Pallini R, Biffoni M, Todaro M, Invernici G, Cenci T, Maira G, Parati EA, Stassi G, Larocca LM, De Maria R (2010) Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells. Nature 468:824-828.
97. Roggendorf W, Strupp S, Paulus W (1996) Distribution and characterization of microglia/macrophages in human brain tumors. Acta Neuropathol (Berl) 92:288-293.
98. Rossi ML, Hughes JT, Esiri MM, Coakham HB, Brownell DB (1987) Immunohistological study of mononuclear cell infiltrate in malignant gliomas. Acta Neuropathol (Berl) 74:269-277.
99. Rubinstein L J (1972) Tumors of the central nervous system. Armed Forces Institute of Pathology, Washington DC 400 pp.
100. Sabel M, Felsberg J, Messing-Junger M, Neuen-Jacob E, Piek J (1999) Glioblastoma multiforme at the site of metal splinter injury: a coincidence? Case report. J Neurosurg 91:1041-1044.
101. Scherer H (1940) The forms of growth in gliomas and their practical significance. Brain 63:1-34.
102. Seyfried TN (2001) Perspectives on brain tumor formation involving macrophages, glia, and neural stem cells. Perspect Biol Med 44:263-282.
103. Seyfried TN, Kiebish MA, Marsh J, Shelton LM, Huysentruyt LC, Mukherjee P (2011) Metabolic management of brain cancer. Biochim Biophys Acta 1807:577-594.
104. Seyfried TN, Shelton LM (2010) Cancer as a metabolic disease. Nutr Metab (Lond) 7:7.
105. Seyfried TN, Shelton LM, Mukherjee P (2010) Does the existing standard of care increase glioblastoma energy metabolism? Lancet Oncol 11:811-813.
106. Shabo I, Olsson H, Sun XF, Svanvik J (2009) Expression of the macrophage antigen CD163 in rectal cancer cells is associated with early local recurrence and reduced survival time. Int J Cancer 125:1826-1831.
107. Shelton LM, Huysentruyt LM, Mukherjee P, Seyfried TN (2010a) Calorie restriction as an anti-invasive therapy for malignant brain cancer in the VM mouse. ASN NEURO 2:e00038.
108. Shelton LM, Mukherjee P, Huysentruyt LC, Urits I, Rosenberg JA, Seyfried TN (2010b) A novel pre-clinical in vivo mouse model for malignant brain tumor growth and invasion. J Neurooncol 99:165-176.
109. Shinonaga M, Chang CC, Suzuki N, Sato M, Kuwabara T (1988) Immunohistological evaluation of macrophage infiltrates in brain tumors. Correlation with peritumoral edema. J Neurosurg 68:259-265.
110. Sica A, Saccani A, Mantovani A (2002) Tumor-associated macrophages: a molecular perspective. Int Immunopharmacol 2:1045-1054.
111. Sica A, Schioppa T, Mantovani A, Allavena P (2006) Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy. Eur J Cancer 42:717-727.
112. Singh KK, Kulawiec M, Still I, Desouki MM, Geradts J, Matsui S (2005) Intergenomic cross talk between mitochondria and the nucleus plays an important role in tumorigenesis. Gene 354:140-146.
113. Steinhaus J (1981) Ueber carcinom-einschlusse. Virchows Arch 126:533-535.
114. Stossel T (1999) Mechanical responses of white blood cells. In Inflammation: Basic Principals and Clinical Correlates (Snyderman J, ed.), pp. 661-679. Lippincott Williams and Wilkins, New York.
115. Strojnik T, Kavalar R, Lah TT (2006) Experimental model and immunohistochemical analyses of U87 human glioblastoma cell xenografts in immunosuppressed rat brains. Anticancer Res 26:2887-2900.
116. Strojnik T, Kavalar R, Zajc I, Diamandis EP, Oikonomopoulou K, Lah TT (2009) Prognostic impact of CD68 and kallikrein 6 in human glioma. Anticancer Res 29:3269-3279.
117. Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJ, Janzer RC, Ludwin SK, Allgeier A, Fisher B, Belanger K, Hau P, Brandes AA, Gijtenbeek J, Marosi C, Vecht CJ, Mokhtari K, Wesseling P, Villa S, Eisenhauer E, Gorlia T, Weller M, Lacombe D, Cairncross JG, Mirimanoff RO (2009) Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 10:459-466.
118. Taha M, Ahmad A, Wharton S, Jellinek D (2005) Extra-cranial metastasis of glioblastoma multiforme presenting as acute parotitis. Br J Neurosurg 19:348-351.
119. Takeuchi H, Kubota T, Kitai R, Nakagawa R, Hashimoto N (2008) CD98 immunoreactivity in multinucleated giant cells of glioblastomas: an immunohistochemical double labeling study. Neuropathology 28:127-131.
120. Talmadge JE, Donkor M, Scholar E (2007) Inflammatory cell infiltration of tumors: Jekyll or Hyde. Cancer Metastasis Rev. 3-4:373-400.
121. Tso CL, Shintaku P, Chen J, Liu Q, Liu J, Chen Z, Yoshimoto K, Mischel PS, Cloughesy TF, Liau LM, Nelson SF (2006) Primary glioblastomas express mesenchymal stem-like properties. Mol Cancer Res 4:607-619.
122. van Landeghem FK, Maier-Hauff K, Jordan A, Hoffmann KT, Gneveckow U, Scholz R, Thiesen B, Bruck W, von Deimling A (2009) Post-mortem studies in glioblastoma patients treated with thermotherapy using magnetic nanoparticles. Biomaterials 30:52-57.
123. Vignery, A (2000) Osteoclasts and giant cells: macrophage-macrophage fusion mechanism. Int J Exp Pathol 81:291-304.
124. Vignery A (2005) Macrophage fusion: are somatic and cancer cells possi blepartners? Trends Cell Biol 15:188-193.
125. Vural G, Hagmar B, Walaas L (1996) Extracranial metastasis of glioblastoma multiforme diagnosed by fine-needle aspiration: a report of two cases and a review of the literature. Diagn Cytopathol 15:60-65.
126. Warburg O (1931) The Metabolism of Tumours, p. 327, Richard R. Smith, New York.
127. Warburg O (1956) On the origin of cancer cells. Science 123:309-314.
128. Watters JJ, Schartner JM, Badie B (2005) Microglia function in brain tumors. J Neurosci Res 81:447-455.
129. Waziri A (2010) Glioblastoma-derived mechanisms of systemic immunosuppression. Neurosurg Clin N Am 21:31-42.
130. Wood GW, Morantz RA (1979) Immunohistologic evaluation of the lymphoreticular infiltrate of human central nervous system tumors. J Natl Cancer Inst 62:485-491.
131. Yang L, DeBusk LM, Fukuda K, Fingleton B, Green-Jarvis B, Shyr Y, Matrisian LM, Carbone DP, Lin (2004) Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis. Cancer Cell 6:409-421.
132. Yates AJ (1992) An overview of principles for classifying brain tumors. Mol- Chem-Neuropathol 17:103-120.
133. Yilmaz Y, Lazova R, Qumsiyeh M, Cooper D, Pawelek J (2005) Donor Y chromosome in renal carcinoma cells of a female BMT recipient: visualization of putative BMT-tumor hybrids by FISH. Bone Marrow Transplant 35:1021-1024.
134. Youness E, Barlogie B, Ahearn M, Trujillo JM (1980) Tumor cell phagocytosis. Its occurrence in a patient with medulloblastoma. Arch Pathol Lab Med 104:651-653.
135. Yuan X, Curtin J, Xiong Y, Liu G, Waschsmann-Hogiu S, Farkas DL, Black KL, Yu JS (2004) Isolation of cancer stem cells from adult glioblastoma multiforme. Oncogene 23:9392-9400.
136. Zagzag D, Esencay M, Mendez O, Yee H, Smirnova I, Huang Y, Chiriboga L, Lukyanov E, Liu M, Newcomb EW (2008) Hypoxia- and vascular endothelial growth factor-induced stromal cell-derived factor-1alpha/ CXCR4 expression in glioblastomas: one plausible explanation of Scherer's structures. Am J Pathol 173:545-560.
137. Zhen L, Yufeng C, Zhenyu S, Lei X (2010) Multiple extracranial metastases from secondary glioblastoma multiforme: a case report and review of the literature. J Neurooncol 97:451-457.
138. Zimmer C, Weissleder R, Poss K, Bogdanova A, Wright SC Jr, Enochs WS (1995) MR imaging of phagocytosis in experimental gliomas. Radiology 197:533-538.